BILLERICA, Mass., May 02, 2024--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2024.
TORINO, Italy, May 02, 2024--Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup ("ELITech") for €870 million in cash, excluding the carved out ELITech clinical chemistry business. ELITech is a differentiated, fast growing and profitable provider of systems and assays for molecular diagnostics (MDx), biomedical systems/specialty IVD, and microbiology, with FY 2023 revenue of approximately EUR 150 million, and more than 80% consumables revenue.
With its stock down 17% over the past month, it is easy to disregard Bruker (NASDAQ:BRKR). However, stock prices are...